BEAT HeartBeam, Inc. Insider Trading

CFO Cruickshank bought 31,250 shares of BEAT at $0.80 (now $0.81); stock down 76.4% from 52-week high amid cluster buy by 7 other insiders.

CFO Tim Cruickshank purchased 31,250 shares at $0.80 on 2026-04-16, increasing his holdings by 76.3% to 72,230 shares. The transaction occurs within a broader cluster pattern: 7 other insiders also bought within the past 14 days. The stock trades at $0.81 today, down 76.4% from its 52-week high of $3.44 and down 37.7% over the past 30 days, indicating significant recent selling pressure. The company is unprofitable, with net income of $-5,255,000.00 over its most recent full fiscal year. Cruickshank's prior buy at this ticker on 2025-02-14 resulted in a -7.4% return over 90 days, and his cross-ticker track record shows a 0.00% win rate on prior buys at the 90-day mark, suggesting his timing choices have not historically preceded price appreciation.

Director Ortigas-Wedekind bought 25,000 shares at $0.80 as stock down -76.4% from 52-week high; 7 other insiders also bought within 14 days.

Director Ortigas-Wedekind purchased 25,000 shares at $0.80 on 2026-04-16, increasing holdings by 22.3% to 137,293 shares total. This transaction occurred amid significant price deterioration: the stock trades at $0.81, down -76.4% from its 52-week high of $3.44 and -37.7% over the past 30 days. The purchase is part of a cluster pattern with 7 other insiders also buying within the past 14 days. The company is unprofitable with net income of $-5,255,000.00 over the most recent full fiscal year, and the market cap stands at $33,281,175.51. The cluster buy activity at severely depressed price levels may reflect insider assessment of fundamental value, though the company's negative profitability warrants scrutiny of whether this represents opportunistic accumulation or a misjudgment of ongoing deterioration.

Director Jaff Michael R bought 31.2K shares of BEAT at $0.80; 7 other insiders also bought in past 14 days amid -76.4% decline from 52-week high

Director Jaff Michael R purchased 31,250 shares at $0.80 on 2026-04-16, establishing a new position of 31.2K shares, as part of a broader cluster pattern where 7 other insiders also bought within the past 14 days. The transaction occurs in the context of significant stock deterioration: the current price of $0.81 reflects a -76.4% decline from the 52-week high of $3.44, and the stock has fallen -37.7% over 30 days and -61.1% over 90 days. The company is operationally unprofitable with a full-year net income of $-5,255,000.00 and a market capitalization of $33,281,175.51. The multi-insider buy cluster during a period of steep price decline warrants investor attention to the underlying rationale and conviction level supporting these transactions.

Director Elfrink Willem buys 187,500 shares at $0.80; stock down 76.4% from 52-week high with 7 other insiders buying in past 14 days

Elfrink Willem, a director, purchased 187,500 shares at $0.80 on 2026-04-16, increasing his holdings by 53.4% to 538,667 shares. This purchase occurred against a backdrop of severe price deterioration: the stock trades at $0.81, down 76.4% from its 52-week high of $3.44 and down 37.7% over the past 30 days. More significantly, seven other insiders also bought within the past 14 days, forming a cluster buy pattern. However, the company's fundamentals remain deeply troubled—HeartBeam reported a net income of $-5,255,000 over its most recent full fiscal year with a market cap of only $33,281,175.51. The convergence of multiple insider purchases amid sharp price declines and persistent unprofitability presents a complex signal that requires scrutiny: while cluster buying can reflect insider conviction, it occurs in a context where the underlying business is generating substantial losses and the stock has suffered a sharp recent selloff.

Director Ferrari Richard purchases 62,500 shares of BEAT at $0.80 amid cluster buying; stock down 76.4% from 52-week high.

Director Ferrari Richard bought 62,500 shares at $0.80 on 2026-04-16, increasing his holdings by 27.3% to 291.6K shares. The purchase occurs in a cluster pattern—7 other insiders also bought within the past 14 days—which often reflects coordinated confidence or a response to an external catalyst. However, context is concerning: HeartBeam is unprofitable with net income of $-5.3M over its most recent full fiscal year, and the stock is trading -76.4% from its 52-week high and down 37.7% over the past 30 days. Richard's prior buy at this ticker in February 2025 generated a 90-day return of -7.4%, and his cross-ticker track record shows a 0.00% win rate on buys over the 90-day measurement period. The timing of this purchase against recent steep declines and the company's losses requires scrutiny into whether underlying fundamentals have stabilized or whether the cluster buying reflects desperation rather than conviction.

Director Vajdic buys 31,250 shares of BEAT at $0.80; 7 other insiders also bought within 14 days amid -76.4% YTD slide.

Director Vajdic purchased 31,250 shares at $0.80 on 2026-04-16, increasing his holdings to 909,914 shares (+3.6% vs pre-transaction). This transaction is part of a cluster pattern: 7 other insiders also bought within the past 14 days. The timing occurs as the stock trades at $0.81, down -76.4% from its 52-week high of $3.44 and down -37.7% over the prior 30 days. The company reported net income of $-5,255,000.00 for its most recent full fiscal year, indicating material operational losses. The coordinated buying activity across multiple insiders at depressed price levels, against a backdrop of significant shareholder value destruction, warrants examination of whether insiders possess information about a potential turnaround or stabilization that is not yet reflected in market pricing.

Director Strome buys 750.0K shares of BEAT at $0.80; stock down 76.4% from 52-week high; 7 other insiders bought in 14 days

Director Mark E. Strome purchased 750,000 shares at $0.80 on 2026-04-16, increasing his holdings by 25.9% to 3.65M shares. The purchase occurs in a cluster context: 7 other insiders also bought within the past 14 days. However, this coordinated activity and the stock's deteriorating fundamentals—HeartBeam reported a net loss of $-5.3M on a $33.3M market cap—warrant scrutiny against Strome's own cross-ticker track record, which shows 3 prior buys with an average 90-day return of -20.0% and a 0.00% win rate. The stock is currently trading at $0.81, down 76.4% from its 52-week high of $3.44 and down 37.7% over the past 30 days, creating an apparent disconnect between the concentrated buying activity and the stock's steepening price deterioration.

President Robert Paul ENO bought 12,500 shares of BEAT at $0.80; 7 other insiders also bought in past 14 days amid -61.1% 90-day decline.

ENO purchased 12,500 shares at $0.80, increasing his holdings by 51.6% from 24,242 to 36,742 shares. This transaction is part of a cluster pattern, with 7 other insiders also buying within the past 14 days. The stock is down -61.1% over 90 days and trades at $0.81 (current price), near the bottom of its 52-week range of $0.58–$3.44 and -76.4% below the 52-week high. The company reported a full-year net income of $-5,255,000.00, indicating ongoing unprofitability. The synchronized insider buying across multiple executives at depressed valuation levels warrants investor attention to both the concentration of insider activity and the underlying operational and financial trajectory that may be driving the accumulation.

CFO Cruickshank Tim bought 17,647 shares at $1.70 on 2025-02-14 in unprofitable HeartBeam Inc. (BEAT); stock down 25.4% in 90 days.

Cruickshank Tim, the CFO, initiated a first-time position of 17,647 shares at $1.70 totaling $29,999.90, occurring as HeartBeam's stock has declined 25.4% over the past 90 days and 35.4% from its 52-week high of $3.22. The company is unprofitable with a net income of $-4,979,000.00 over its most recent full fiscal year. This open-market purchase by a newly-transacting insider in a low-price micro-cap ($55.5M market cap) contrasts sharply with the company's negative fundamentals and sustained downtrend, raising questions about the CFO's assessment of valuation or forward prospects relative to the observed market trajectory.

Director Ferrari Richard bought 29,412 shares of BEAT at $1.70 on 2025-02-14 ($50.0K); stock down -25.4% over 90 days amid -$5.0M net loss.

Ferrari Richard, a director, purchased 29,412 shares at $1.70, increasing his holdings by 19.6% to 179,136 shares post-transaction. The company reported a -$5.0M net loss over its most recent fiscal year and trades with a $55.5M market cap. The stock has declined -25.4% over the past 90 days and is trading -35.4% below its 52-week high of $3.22, creating a context of sustained downward momentum. The purchase occurred at a point of material weakness, but the underlying fundamentals remain negative, making the significance of this director-level accumulation moderate rather than a clear conviction signal.